Infection in systemic lupus erythematosus.
The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.
Petri
M
M
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
D001424:Bacterial Infections / Q000150:complications* / Q000276:immunology / Q000401:mortality; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000382:microbiology* / Q000401:mortality / Q000821:virology*; D009181:Mycoses / Q000150:complications* / Q000276:immunology / Q000401:mortality; D014777:Virus Diseases / Q000150:complications* / Q000276:immunology / Q000401:mortality